FastPoll™ for the Week of September 25, 2016

How severe would your condition have to be in order for you to take a medicine that has shown promise in clinical trials, but the FDA did not approve it based on a lack of scientific rigor? (By the way, these are the scales used in SAE reports – just dropping some second-level info on you)

ic_poll_9_26_16

Now don't be stingy. Share this.Share on FacebookShare on Google+Tweet about this on TwitterShare on LinkedIn

4. Weight loss made easy?

Do I really need that brownie? This age-old question possibly just became easier to answer for some. The FDA has approved a new weight-loss device for obese patients. AspireAssist is a surgically-placed tube that drains stomach contents into the toilet (~30% of calories consumed at the prior meal). A clinical trial followed two groups of patients over a one-year period. All patients received nutrition and exercise advice but only one group of patients used the device. AspireAssist users lost an average of 12.1% of their bodyweight while the control group reduced bodyweight by 3.6%.  Social media commentary has been mixed with some likening the device to bulimia. Time will reveal patient and physician receptivity to AspireAssist. We’ll leave it to the waistlines to judge its effectiveness.

Now don't be stingy. Share this.Share on FacebookShare on Google+Tweet about this on TwitterShare on LinkedIn